ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.63
0.12%
US Tech 100
21,156.80
-0.70%
S&P 500
6,101.24
-0.29%
US Dollar vs CAD
1.44878
0.00%
Bitcoin
104,453.29
-0.26%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. N4 Pharma Plc (N4P) Share Price

N4 Pharma Plc

N4 Pharma Plc (N4P)

LSE
0.65
0.00
(0.00%)
Closed January 26 10:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.65
Bid
0.60
Ask
0.70
Volume
519,217
0.6175 Day's Range 0.65
0.412 52 Week Range 0.925
Market Cap
2.566M
Previous Close
0.65
Open
0.65
Last Trade
400000
@
0.67
(O)
Last Trade Time
Financial Volume
3,063p
VWAP
0.59
Average Volume (3m)
1,891,099
Shares Outstanding
394,780,000
Dividend Yield
-
PE Ratio
-2.03
Earnings Per Share (EPS)
-0
Revenue
2k
Net Profit
-1.27M

About N4 Pharma Plc

Sector
Drug & Proprietary Stores
Industry
Computer & Office Equipment
Website
www.n4pharma.com
Headquarters
Derbyshire, Gbr
Founded
1990
N4 Pharma Plc is listed in the Drug & Proprietary Stores sector of the London Stock Exchange with ticker N4P. The last closing price for N4 Pharma was 0.65p. Over the last year, N4 Pharma shares have traded in a share price range of 0.412p to 0.925p.

N4 Pharma currently has 394,780,000 shares outstanding. The market capitalization of N4 Pharma is £2.57 million. N4 Pharma has a price to earnings ratio (PE ratio) of -2.03.

Ask ADVFN Intelligence (AI)

N4P Latest News

More News

N4 Pharma PLC N4 Pharma Non-Executive Director Q&A

N4 Pharma PLC 16 January 2025       ​ 16 January 2025 N4 Pharma plc   ("N4 Pharma" or the "Company")   N4 Pharma Non-Executive Director Q&A   N4 Pharma plc (AIM: N4P), the biotech...

January 16 2025
RNS Non-Regulatory

N4 Pharma PLC Directorate Changes

N4 Pharma PLC 08 January 2025     8 January 2025 N4 Pharma plc   ("N4 Pharma" or the "Company")   Directorate Changes   N4 Pharma plc (AIM: N4P), the biotech developing Nuvec®, its proprietary...

January 08 2025
RNS Regulatory News

N4 Pharma PLC N4 101 In Vitro Results

N4 Pharma PLC 12 December 2024   12 December 2024 N4 Pharma plc ("N4 Pharma" or the "Company")   N4 101 in vitro Results Latest data demonstrate key benefits of the Nuvec® delivery platform  ...

December 12 2024
RNS Regulatory News

N4 Pharma PLC New Patent Filing

N4 Pharma PLC 04 December 2024   4 December 2024 N4 Pharma plc ("N4 Pharma" or the "Company")   New Patent Filing   N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing...

December 04 2024
RNS Regulatory News

N4 Pharma PLC Grant of Options

N4 Pharma PLC 28 November 2024     28 November 2024   N4 Pharma plc ("N4 Pharma" or the "Company")   Grant of Options   N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company...

November 28 2024
RNS Regulatory News

N4 Pharma PLC N4 Pharma CEO Q&A Now LIVE

N4 Pharma PLC 01 November 2024     N4 Pharma plc  ("N4 Pharma" or the "Company")   N4 Pharma CEO Q&A Now LIVE   N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing...

November 01 2024
RNS Non-Regulatory

N4 Pharma PLC New Corporate Presentation

N4 Pharma PLC 24 October 2024     N4 Pharma plc  ("N4 Pharma" or the "Company")   New Corporate Presentation and CEO Q&A   N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company...

October 24 2024
RNS Non-Regulatory

EARNINGS: Metals One advances Black Schist, N4 generates revenue

The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by ...

September 24 2024
Alliance News

N4 Pharma PLC Interim Results

N4 Pharma PLC 24 September 2024    24 September 2024 N4 Pharma Plc ("N4 Pharma" or the "Company") Interim Results N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing...

September 24 2024
RNS Regulatory News

N4 Pharma PLC SRI Research Update

N4 Pharma PLC 17 September 2024   17 September 2024 N4 Pharma plc ("N4 Pharma" or the "Company")   SRI Research Update   N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company...

September 17 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.025-3.70370370370.6750.6750.617510847970.66670061DE
40.12523.80952380950.5250.80.52529937680.6557738DE
120.02540.6250.80.52518910990.65860308DE
260.244.44444444440.450.80.4515686240.61743802DE
52-0.275-29.72972972970.9250.9250.41211432160.63415776DE
156-2.8-81.15942028993.453.950.4129812111.37759573DE
260-2.85-81.42857142863.515.50.41215140485.63738226DE

N4P - Frequently Asked Questions (FAQ)

What is the current N4 Pharma share price?
The current share price of N4 Pharma is 0.65p
How many N4 Pharma shares are in issue?
N4 Pharma has 394,780,000 shares in issue
What is the market cap of N4 Pharma?
The market capitalisation of N4 Pharma is GBP 2.57M
What is the 1 year trading range for N4 Pharma share price?
N4 Pharma has traded in the range of 0.412p to 0.925p during the past year
What is the PE ratio of N4 Pharma?
The price to earnings ratio of N4 Pharma is -2.03
What is the reporting currency for N4 Pharma?
N4 Pharma reports financial results in GBP
What is the latest annual turnover for N4 Pharma?
The latest annual turnover of N4 Pharma is GBP 2k
What is the latest annual profit for N4 Pharma?
The latest annual profit of N4 Pharma is GBP -1.27M
What is the registered address of N4 Pharma?
The registered address for N4 Pharma is 6 TH FLOOR, 60 GRACECHURCH STREET, LONDON,UNITED KINGDOM, DERBYSHIRE, EC3V 0HR
What is the N4 Pharma website address?
The website address for N4 Pharma is www.n4pharma.com
Which industry sector does N4 Pharma operate in?
N4 Pharma operates in the COMPUTER & OFFICE EQUIPMENT sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PPSProton Motor Power Systems Plc
0.325p
(85.71%)
4.07M
CTAICatenai Plc
0.255p
(34.21%)
79.48M
MILAMila Resources Plc
0.23p
(31.43%)
27.89M
SNGSynairgen Plc
2.34p
(26.66%)
6.36M
GILDGuild Esports Plc
0.05p
(25.00%)
34.84M
QEDQuadrise Plc
4.01p
(-31.10%)
213.11M
EMEEmpyrean Energy Plc
0.1075p
(-23.21%)
305.19M
EXREngage Xr Holdings Plc
1.55p
(-20.92%)
12.64M
RNWHRenew Holdings Plc
720.00p
(-20.79%)
2.45M
UKRUkrproduct Group Limited
2.00p
(-20.00%)
1.25k
PREMPremier African Minerals Limited
0.0245p
(-2.00%)
2.6B
TRPTower Resources Plc
0.0295p
(7.27%)
1.07B
EMEEmpyrean Energy Plc
0.1075p
(-23.21%)
305.19M
QEDQuadrise Plc
4.01p
(-31.10%)
213.11M
RRRRed Rock Resources Plc
0.0525p
(-4.55%)
198.76M

Discussion

View Full Feed
littlerhody littlerhody 8 minutes ago
DrSleep, While you are there wake up the folks responsible for putting some ELTP news out there. The IR department seems to be in a self induced coma!!!
ELTP
bobby1151 bobby1151 8 minutes ago
What might be YOUR scenario be for BIEL with a Viant Medical buyout?????????????????
BIEL
Wingsjr Wingsjr 8 minutes ago
47 will decide and Bessent and Pulte will make it happen.
FNMA
TenKay TenKay 8 minutes ago
“Now... you admit that the asset value is at least $52mil.“

Now? LOL. I see in your review of my prior posts, you missed a subsequent post.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175654875&txt2find=Round

I originally was giving yo
HMBL
splintered sunlight splintered sunlight 9 minutes ago
I guess we will wait and see.........
YBCN
Smartypants2 Smartypants2 9 minutes ago
Even with the help of AI, you still don't understand that XERI was never obligated to invest $10 million! That was the UPPER LIMIT of what it could choose to invest in the development work required to complete the PDR (Preliminary Design Review) which was actually completed prior to the 12-month dea
XERI
jimr1717 jimr1717 9 minutes ago
Newbies Updated DD 🏆️ >>, Marc Walther was found liable in a securities fraud lawsuit...

Complaint:
https://drive.google.com/file/d/1Wpk0lRCJaTOI3dmR_BeSNw6eWtnTt71s/view

Judgement: $397,744.50
https://drive.google.com/file/d/1nZjmmsmCwJlFw
HGYN HYGN
Thehubby Thehubby 10 minutes ago
Shouldn't the only issue today is THE BILLS BEATING THE CHIEFS??!!
AVXL
MasterBlastr MasterBlastr 11 minutes ago
Well you have to start looking at the Oligarchs (Trump's 12 Disciples) now -
AMC
ORCA ORCA 12 minutes ago
AXXA=THE BIGGEST SCAM EVER.I HOPE IT GOES TO ZERO BID.
AXXA
splintered sunlight splintered sunlight 12 minutes ago
Appears that way..........
BBUZ
EZmoney- EZmoney- 12 minutes ago
Time to get this rocket movin !!!

WCVC

Ez~
ChannelTrader ChannelTrader 12 minutes ago
Nice Lift happening.

$AKEMF
AKEMF
ORCA ORCA 13 minutes ago
I REALLY HOPE THE SEC SHUTS THIS DOWN THIS COMING WEEK.SO YOU CAN LOSE ALL YOUR MONEY SCAMBAG
AXXA
Myth Myth 15 minutes ago
crazy game so far, took the Redskins over 10 1/2 2nd half....
EZmoney- EZmoney- 15 minutes ago
T53 guess who's back !!!
Truthsocial Truthsocial 16 minutes ago
FO DF

So you are indicating RDGL lied in their pr ...

https://www.biospace.com/press-releases/vivos-inc-announces-launch-of-groundbreaking-radiogel-precision-radionuclide-therapy-human-clinical-trial
RDGL
ChannelTrader ChannelTrader 16 minutes ago
That would solve the problem.
Golden Cross Golden Cross 17 minutes ago
💲 000 Stocks Can make You Rich!
Golden Cross Golden Cross 18 minutes ago
💲 000 Stocks Can make You Rich!
arizona1 arizona1 18 minutes ago
Trump Supporters Are Begging Him For Their Jobs Back

https://substackcdn.com/image/fetch/w_2250,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fe1724342-3fad-42ff-b838-435b57d6caad_1125x720.jpeg

http

Your Recent History

LSE
N4P
N4 Pharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads